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Feasibility of four patient reported outcome measures in the Danish Hip Arthroplasty Registry. 
A cross-sectional study of 6000 patients.
Introduction: 
Validated patient reported outcome 
measurement systems (PROs) after total hip 
arthroplasty (THA) are warranted in the Danish 
Hip Arthroplasty Registry (DHR), as well as 
in other national hip arthroplasty registries. 
We therefore validated four PROs measuring 
quality of life, pain and hip function. 
Aim:
Our aim was to assess response rate, floor/
ceiling effect, missing items, and cost of PROs 
relevant to THA patients in a register setting. 
Material and Methods: 
5747 primary THA patients, operated 1-2, 5-6, 
and 10-11 years ago, irrespective of diagnose 
were randomly selected from the Danish Hip 
Arthroplasty Registry. Every patient received 
two different PROs, one general and one 
disease/site-specific. Based on previous 
literature, SF-12 Health Survey (SF12), EQ-
5D, Oxford 12-item Hip Score (OHS), and Hip 
dysfunction and Osteoarthritis Outcome Score 
(HOOS) were included. HOOS subscales 
(Pain, Physicalfunction Shortform (PS) and 
Quality of Life (QoL)) and EQ5D Index and 
EQ5D VAS were used. 
Cost was assessed as license requirements, 
fees and need for manual validation of the 
scanned questionnaires.
Results: 
5206/5747 (91%) patients (mean age 72 years, 
59% females) responded. Non-responders 
did not differ from responders with regard to 
age and gender. Response rates for the PROs 
were 82-84%. The floor effect was <0.5% for all 
PROs. Ceiling effects ranged from 46% (EQ-
5D Index), to 6% (SF-12). 
Percentage of missing items ranged from 
15% (HOOS Pain) to 3% (HOOS QoL and 
EQ-5D Index). When applying questionnaire 
specific rules for missing items, a score could 
not be calculated for 1-6% of the PROs. The 
proportion of items needing manual validation 
ranged from 4% (EQ-5D) to 1% (SF-12, 
HOOS). 
OHS and HOOS do not acquire any license. 
For SF-12 administrative fee, survey reference 
kit, and scoring software cost altogether 
1,569.90 USD. Since less than 5000 patients 
received EQ-5D, we could use EQ-5D free 
of charge and without sharing data with the 
EuroQol Group.
Figure: Patient flow chart 
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Table: Results 
 
HOOS % 
(95% CI) 
 
N= 2365 
SF-12 % 
(95% CI) 
 
N= 2377 
EQ-5D % 
(95% CI) 
 
N= 2407 
 
All patients 
Pain PS QoL 
OHS % 
(95% CI) 
 
N= 2419 
PCS MCS Index VAS 
 
 
Response rate: 
accepted participation 
and answered the 
PROs 
 
82.4% 
(81.0-83.8) 
 
84.1% 
(82.7-85.4) 
 
82.6% 
(81.2-84.0) 
 
83.9% 
(82.6-85.2) 
 
Floor effect 
Worst outcome 
 
 
0.1% 
(0-0.2) 
 
0.1% 
(0-0.3) 
 
0.5% 
(0.3-0.8) 
 
0.0% 
 
0.1% 
(0-0.3) 
 
0.1% 
(0-0.3) 
 
0.0% 
 
 
0.3% 
(0.1-0.5) 
 
Ceiling effect 
Best outcome 
 
 
36.6% 
(34.6-38.5) 
 
31.2% 
(29.3-33.1) 
 
30.5% 
(28.6-32.3) 
 
20.2% 
(18.6-21.8) 
 
6.1% 
(5.1-7.0) 
 
6.1% 
(5.1-7.0) 
 
45.8% 
(43.8-47.8) 
 
12.1% 
(10.8-13.4) 
 
Discarded PROs 
subscales 
 
 
3.0% 
(2.4-3.7) 
 
2.7% 
(2.1-3.4) 
 
1.9% 
(1.3-2.5) 
 
1.2% 
(0.8-1.7) 
 
2.3% # 
(1.7-2.9) 
 
2.3% # 
(1.7-2.9) 
 
3.2% 
(2.5-3.9) 
 
5.5% 
(4.6-6.4) 
 
PROs with 
missing items/ 
PROs(subscales) 
 
 
14.6% 
(13.2-16.1) 
 
9.0% 
(7.8-10.1) 
 
3.2% 
(2.5-3.9) 
 
5.4% 
(4.5-6.3) 
 
9.9% 
(8.7-11.1) 
 
9.9% 
(8.7-11.1) 
 
3.2% 
(2.5-3.9) 
 
5.5% 
(4.6-6.4) 
 
Proportion of 
items missing 
 
 
3.4% 
(3.2-3.5) 
 
1.2% 
(1.0-1.3) 
 
2.3% 
(2.1-2.5) 
 
1.9% 
(1.7-2.2) 
 
PROs with 
manual 
validation/PROs 
 
7.8% 
(6.7-8.9) 
 
7.2% 
(6.2-8.2) 
 
7.7% 
(6.7-8.8) 
 
21.8% 
(20.2-23.4) 
 
PROs with 
manual 
validation/PROs 
subscales 
 
4.3% 
(3.5-5.1) 
 
2.6% 
(2.0-3.3) 
 
2.5% 
(1.9-3.1) 
 
7.2% 
(6.2-8.2) 
 
7.7% 
(6.6-8.8) 
 
7.7% 
(6.6-8.8) 
 
4.1% 
(3.3-4.9) 
 
18.8% 
(17.3-20.4) 
 
Proportion of 
items  
validated 
 
0.9% 
(0.8-1.0) 
 
1.5% 
(1.4-1.7) 
 
0.8% 
(0.7-1.0) 
 
4.3% 
(4.0-4.6) 
 
Licence 
 
 
No 
 
 
No 
 
Yes 
 
 
Yes 
 
 
Cost 
 
 
Free 
 
Free 
 
1,569.90 USD * 
 
Free ¤ 
 
 
Type of PROs 
 
Disease- or site-specific PROs 
 
General PROs 
 
 
# With missing data estimation method: maximum data recovery. With complete date: 9.9%. 
* Administrative fee, survey reference kit, and scoring software 
¤ Since less than 5000 patients received EQ-5D, we could use EQ-5D free of charge and without sharing data with the EuroQol Group  
Discussion: 
Based on our results, it will now be possible to 
choose appropriate PROs to best fit the needs 
of national hip arthroplasty registries. The low 
floor effects and high ceiling effects can largely 
be explained by postoperative administration 
and the overall good outcome from THA. 
Table: ResultsFigure: Patient flow chart raph: A e groups
Conclusion: 
We conclude that Hip Dysfunction and 
Osteoarthritis Outcome Score (HOOS), 
Oxford Hip Score (OHS), SF-12 and 
EQ-5D are appropriate questionnaires for 
administration in a hip registry.
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